Neuropore Therapiesincis A Biopharmaceutical Company Located In San Diegocaliforniathe Company Focuses On Discovering And Developing Innovative Therapeutics For Neurodegenerative Diseasesparticularly Parkinson S Diseaseneuropore Therapies Aims To Address The Root Causes Of These Conditionsincluding The Accumulation Of Neurotoxic Proteins And Neuroinflammation The Company Has Several Therapeutic Candidates In Its Pipelineincluding Npt520 34 And Npt1220 478Which Are Being Developed As Disease Modifying Treatmentsnpt200 11Another Candidateis An Orally Bioavailable Small Molecule That Targets Toxic Protein Aggregates Associated With Parkinsonae S Diseasethis Candidate Has Successfully Completed A Phase 1 Clinical Trial And Has Been Out Licensed To Ucb Pharmaneuropore Therapies Collaborates With Various Partnersincluding Ucb Pharma And Global Cancer Technologyto Enhance Its Research And Development Effortsthe Company Has Also Received Grants To Support Its Work In Neurodegenerative Disease Research
No conferences found for this company.
| Company Name | Neuropore Therapies Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
